Combination of antiangiogenic and systemic therapy in advanced non-small cell lung cancer: before and after progression to leptomeningeal metastasis
Abstract Leptomeningeal metastasis (LM) is the most devastating complication of non-small cell lung cancer (NSCLC), and its incidence is increasing. We investigated the survival outcomes of patients with NSCLC who received combined antiangiogenic and systemic therapies before and after LM progressio...
Saved in:
| Main Authors: | Xiao-dan Zhu, Re-ha-ti Amanjiaoer, Yan-li Shen, Na Li, Mi-hray Abdurazik, Chun-ling Liu, Gang Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-91922-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug delivery in leptomeningeal disease: Navigating barriers and beyond
by: Numair Arshad, et al.
Published: (2024-12-01) -
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01) -
Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy
by: Mengting Shi, et al.
Published: (2023-12-01) -
Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study
by: Yun-Yi Wang, et al.
Published: (2025-08-01) -
Beyond the brain: exploring the impact of animal models of leptomeningeal disease from solid tumors
by: Jillyn R. Turunen, et al.
Published: (2025-05-01)